{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:18:03Z","timestamp":1786119483548,"version":"build-2736575974"},"reference-count":46,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1097\/cej.0b013e32833233d4","type":"journal-article","created":{"date-parts":[[2010,2,25]],"date-time":"2010-02-25T01:22:19Z","timestamp":1267060939000},"page":"35-41","source":"Crossref","is-referenced-by-count":7,"title":["Biomarkers in cervical screening: quantitative reverse transcriptase PCR analysis of P16INK4a expression"],"prefix":"10.1097","volume":"19","author":[{"given":"Ga\u00eblle A.V.","family":"Boulet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline A.J.","family":"Horvath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe E.","family":"Depuydt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes J.","family":"Bogers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-6-20210128","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1093\/jnci\/djh037","article-title":"Virologic versus cytologic triage of women with equivocal Pap smears: a meta-analysis of the accuracy to detect high-grade intraepithelial neoplasia","volume":"96","author":"Arbyn","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"R3-6-20210128","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ygyno.2005.07.033","article-title":"Clinical utility of HPV-DNA detection: triage of minor cervical lesions, follow-up of women treated for high-grade CIN: an update of pooled evidence","volume":"99","author":"Arbyn","year":"2005","journal-title":"Gynecol Oncol"},{"key":"R1-6-20210128","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1158\/1055-9965.EPI-08-0510","article-title":"Prevaccination distribution of human papillomavirus types in women attending at cervical cancer screening in Belgium","volume":"18","author":"Arbyn","year":"2009","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R4-6-20210128","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nrc1010","article-title":"Translational approaches to improving cervical screening","volume":"3","author":"Baldwin","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"R5-6-20210128","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1093\/clinchem\/48.8.1178","article-title":"Real-time PCR technology for cancer diagnostics","volume":"48","author":"Bernard","year":"2002","journal-title":"Clin Chem"},{"key":"R6-6-20210128","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1136\/jcp.55.4.244","article-title":"The causal relation between human papillomavirus and cervical cancer","volume":"55","author":"Bosch","year":"2002","journal-title":"J Clin Pathol"},{"key":"R7-6-20210128","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1016\/j.biocel.2007.07.004","article-title":"Human papillomavirus: E6 and E7 oncogenes","volume":"39","author":"Boulet","year":"2007","journal-title":"Int J Biochem Cell Biol"},{"key":"R8-6-20210128","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/01.pgp.0000139639.79105.40","article-title":"p16(INK4A) expression is related to grade of CIN and high-risk human papillomavirus but does not predict virus clearance after conization or disease outcome","volume":"23","author":"Branca","year":"2004","journal-title":"Int J Gynecol Pathol"},{"key":"R11-6-20210128","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1158\/1055-9965.EPI-08-0306","article-title":"Human papillomavirus mRNA and p16 detection as biomarkers for the improved diagnosis of cervical neoplasia","volume":"17","author":"Cuschieri","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R9-6-20210128","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/jmv.20062","article-title":"Human papillomavirus type specific DNA and RNA persistence \u2013 implications for cervical disease progression and monitoring","volume":"73","author":"Cuschieri","year":"2004","journal-title":"J Med Virol"},{"key":"R10-6-20210128","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.jviromet.2004.11.005","article-title":"Assessment of human papillomavirus mRNA detection over time in cervical specimens collected in liquid-based cytology medium","volume":"124","author":"Cuschieri","year":"2005","journal-title":"J Virol Methods"},{"key":"R12-6-20210128","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/j.1365-2303.2006.00386.x","article-title":"Improved endocervical sampling and HPV viral load detection by Cervex-Brush Combi","volume":"17","author":"Depuydt","year":"2006","journal-title":"Cytopathology"},{"key":"R13-6-20210128","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1111\/j.1582-4934.2007.00073.x","article-title":"Comparison of MY09\/11 consensus PCR and type-specific PCRs in the detection of oncogenic HPV types","volume":"11","author":"Depuydt","year":"2007","journal-title":"J Cell Mol Med"},{"key":"R14-6-20210128","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S1084-8592(98)80054-4","article-title":"Characterization of RNA in cytologic samples preserved in a methanol-based collection solution","volume":"3","author":"Dimulescu","year":"1998","journal-title":"Mol Diagn"},{"key":"R15-6-20210128","article-title":"GLOBOCAN 2000. Cancer incidence, mortality and prevalence worldwide, version 1.0.","author":"Ferlay","year":"2001"},{"key":"R16-6-20210128","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1158\/1055-9965.492.13.3","article-title":"Molecular quality of exfoliated cervical cells: implications for molecular epidemiology and biomarker discovery","volume":"13","author":"Habis","year":"2004","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R17-6-20210128","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/cncr.22284","article-title":"A comparison of the clinical utility of p16(INK4a) immunolocalization with the presence of human papillomavirus by hybrid capture 2 for the detection of cervical dysplasia\/neoplasia","volume":"108","author":"Holladay","year":"2006","journal-title":"Cancer"},{"key":"R18-6-20210128","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1136\/jcp.2007.047266","article-title":"Effect of fixation on RNA integrity in a liquid-based cervical cytology setting","volume":"61","author":"Horvath","year":"2008","journal-title":"J Clin Pathol"},{"key":"R19-6-20210128","first-page":"S3\/63","article-title":"Chapter 7: achievements and limitations of cervical cytology screening","volume":"24S3","author":"Kitchener","year":"2006","journal-title":"Vaccine"},{"key":"R20-6-20210128","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/ijc.1174","article-title":"Overexpression of p16(INK4a) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri","volume":"92","author":"Klaes","year":"2001","journal-title":"Int J Cancer"},{"key":"R21-6-20210128","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.ygyno.2005.02.026","article-title":"DNA-versus RNA-based methods for human papillomavirus detection in cervical neoplasia","volume":"97","author":"Lie","year":"2005","journal-title":"Gynecol Oncol"},{"key":"R22-6-20210128","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/dc.20763","article-title":"Application of flow cytometry for biomarker-based cervical cancer cells detection","volume":"36","author":"Ling","year":"2008","journal-title":"Diagn Cytopathol"},{"key":"R23-6-20210128","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/978-1-59745-447-6_15","article-title":"Gene expression profiling in cervical cancer: identification of novel markers for disease diagnosis and therapy","volume":"511","author":"Martin","year":"2009","journal-title":"Methods Mol Biol"},{"key":"R24-6-20210128","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/cncr.22580","article-title":"Evaluation of p16INK4a expression in ThinPrep cervical specimens with the CINtec p16INK4a assay: correlation with biopsy follow-up results","volume":"11","author":"Meyer","year":"2007","journal-title":"Cancer"},{"key":"R25-6-20210128","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1158\/1055-9965.EPI-04-0410","article-title":"Comparison of human papillomavirus messenger RNA and DNA detection: a cross-sectional study of 4136 women >30 years of age with a 2-year follow-up of high-grade squamous intraepithelial lesion","volume":"14","author":"Molden","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R26-6-20210128","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jviromet.2007.01.036","article-title":"PreTect HPV-Proofer: real-time detection and typing of E6\/E7 mRNA from carcinogenic human papillomaviruses","volume":"142","author":"Molden","year":"2007","journal-title":"J Virol Methods"},{"key":"R27-6-20210128","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/00008469-200002000-00002","article-title":"Risk factors for pre-cancerous lesions of the cervix","volume":"9","author":"Murthy","year":"2000","journal-title":"Eur J Cancer Prev"},{"key":"R28-6-20210128","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/1096-9071(200010)62:2<251::AID-JMV18>3.0.CO;2-V","article-title":"Ubiquitous presence of E6 and E7 transcripts in human papillomavirus-positive cervical carcinomas regardless of its type","volume":"62","author":"Nakagawa","year":"2000","journal-title":"J Med Virol"},{"key":"R29-6-20210128","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1056\/NEJMoa073204","article-title":"Human papillomavirus and Papanicolaou tests to screen for cervical cancer","volume":"18","author":"Naucler","year":"2007","journal-title":"N Engl J Med"},{"key":"R30-6-20210128","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.ctrv.2003.07.008","article-title":"The role of HPV DNA testing in the follow-up period after treatment for CIN: a systematic review of the literature","volume":"30","author":"Paraskevaidis","year":"2004","journal-title":"Cancer Treat Rev"},{"key":"R31-6-20210128","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/j.vaccine.2006.05.111","article-title":"Chapter 2: the burden of HPV-related cancers","volume":"24","author":"Parkin","year":"2006","journal-title":"Vaccine"},{"key":"R32-6-20210128","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1046\/j.1365-2303.2000.00291.x","article-title":"Liquid-based cytology for cervical screening","volume":"11","author":"Payne","year":"2000","journal-title":"Cytopathology"},{"key":"R33-6-20210128","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jviromet.2006.05.033","article-title":"Recovery of human papillomavirus nucleic acids from liquid-based cytology media","volume":"137","author":"Powell","year":"2006","journal-title":"J Virol Methods"},{"issue":"1","key":"R34-6-20210128","doi-asserted-by":"crossref","first-page":"S230","DOI":"10.1016\/j.ygyno.2007.07.021","article-title":"The New Technologies for Cervical Cancer Screening randomised controlled trial. An overview of results during the first phase of recruitment","volume":"107","author":"Ronco","year":"2007","journal-title":"Gynecol Oncol"},{"key":"R36-6-20210128","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1002\/ijc.11589","article-title":"p16INK4a as an adjunct marker in liquid-based cervical cytology","volume":"108","author":"Sahebali","year":"2004","journal-title":"Int J Cancer"},{"key":"R35-6-20210128","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1002\/ijc.21489","article-title":"Immunocytochemistry in liquid-based cervical cytology: analysis of clinical use following a cross-sectional study","volume":"118","author":"Sahebali","year":"2006","journal-title":"Int J Cancer"},{"key":"R37-6-20210128","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/dc.10205","article-title":"Overexpression of p16INK4A in liquid-based specimens (SurePath) as a maker of cervical dysplasia and neoplasia","volume":"27","author":"Saqi","year":"2002","journal-title":"Diagn Cytopathol"},{"key":"R38-6-20210128","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1001\/jama.287.16.2114","article-title":"The 2001 Bethesda System: terminology for reporting results of cervical cytology","volume":"287","author":"Solomon","year":"2002","journal-title":"JAMA"},{"key":"R39-6-20210128","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2353\/jmoldx.2006.050088","article-title":"DNA and RNA references for qRT-PCR in exfoliated cervical cells","volume":"8","author":"Steinau","year":"2006","journal-title":"J Mol Diagn"},{"key":"R40-6-20210128","doi-asserted-by":"crossref","first-page":"125","DOI":"10.2165\/00066982-200106020-00007","article-title":"Improved detection of viral RNA isolated from liquid-based cytology samples","volume":"6","author":"Tarkowski","year":"2001","journal-title":"Mol Diagn"},{"key":"R42-6-20210128","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.ctrv.2008.10.005","article-title":"p16(INK4a) immunostaining in cytological and histological specimens from the uterine cervix: a systematic review and meta-analysis","volume":"35","author":"Tsoumpou","year":"2009","journal-title":"Cancer Treat Rev"},{"key":"R43-6-20210128","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/cncr.21378","article-title":"Evaluation of a nuclear score for p16INK4a-stained cervical squamous cells in liquid-based cytology samples","volume":"105","author":"Wentzensen","year":"2005","journal-title":"Cancer"},{"key":"R44-6-20210128","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1093\/clinchem\/46.11.1738","article-title":"Influence of DNA target melting behavior on real-time PCR quantification","volume":"46","author":"Wilhelm","year":"2000","journal-title":"Clin Chem"},{"key":"R45-6-20210128","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/GRF.0b013e31804a8285","article-title":"Cervical cancer screening in the 21st century: is it time to retire the PAP smear?","volume":"50","author":"Wright","year":"2007","journal-title":"Clin Obstet Gynecol"},{"key":"R46-6-20210128","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.prp.2007.03.010","article-title":"Efficiency of immunohistochemical p16 expression and HPV typing in cervical squamous intraepithelial lesion grading and review of the p16 literature","volume":"203","author":"Yildiz","year":"2007","journal-title":"Pathol Res Pract"},{"key":"R47-6-20210128","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1097\/00006254-200407000-00024","article-title":"HPV testing and monitoring of women after treatment of CIN 3: review of the literature and meta-analysis","volume":"59","author":"Zielinski","year":"2004","journal-title":"Obstet Gynecol Surv"}],"container-title":["European Journal of Cancer Prevention"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00008469-201001000-00006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:16:11Z","timestamp":1786040171000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00008469-201001000-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/cej.0b013e32833233d4","relation":{},"ISSN":["0959-8278"],"issn-type":[{"value":"0959-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]}}}